Undaunted by questions surrounding the power of genomics to impact drug and diagnostics development and the crush of companies rushing to reposition themselves as protein- not gene-focused, Exact Sciences Corp.(formerly Exact Laboratories Inc.) stubbornly insists on being known as an applied genomics company. The characterization is right on. The cancer diagnostics company does not seek to discover genes or disease-associated targets; rather, it takes already-known genomics discoveries into the clinical diagnostics setting. With the May announcement of the availability of its first test, the company is gaining visibility and traction.
What Exact brings to the table is a proprietary purification technology it uses to isolate human DNA from the much...
